• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一种选择性5-羟色胺能药物(丁螺环酮)治疗近期戒酒的酒精依赖人群中的共病广泛性焦虑症。

Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).

作者信息

Tollefson G D, Montague-Clouse J, Tollefson S L

机构信息

Department of Psychiatry, Ramsey Clinic, St. Paul, Minnesota.

出版信息

J Clin Psychopharmacol. 1992 Feb;12(1):19-26. doi: 10.1097/00001573-199202000-00004.

DOI:10.1097/00001573-199202000-00004
PMID:1552035
Abstract

Recent literature has addressed a common dyad: alcoholism and anxiety. Both disorders have been interdigitated with the brain amine serotonin. We investigated 51 dually diagnosed patients (generalized anxiety/alcohol abuse:dependence) in a randomized, double-blind, placebo-controlled trial of the serotonin partial agonist buspirone. Buspirone was superior to placebo as an anxiolytic, was well tolerated, and was associated with both a reduction in the number of days desiring alcohol and an overall clinical global improvement.

摘要

近期文献探讨了一个常见的二元组

酗酒和焦虑。这两种病症都与脑胺血清素相互关联。我们在一项针对血清素部分激动剂丁螺环酮的随机、双盲、安慰剂对照试验中,对51名双重诊断患者(广泛性焦虑/酒精滥用:依赖)进行了研究。丁螺环酮作为一种抗焦虑药优于安慰剂,耐受性良好,并且与渴望饮酒天数的减少以及整体临床综合改善相关。

相似文献

1
Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).用一种选择性5-羟色胺能药物(丁螺环酮)治疗近期戒酒的酒精依赖人群中的共病广泛性焦虑症。
J Clin Psychopharmacol. 1992 Feb;12(1):19-26. doi: 10.1097/00001573-199202000-00004.
2
The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.丁螺环酮及其代谢物1-嘧啶基哌嗪在缓解伴有抑郁特征的共病焦虑和酒精依赖中的关联。
Psychopharmacol Bull. 1991;27(2):163-70.
3
Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.丁螺环酮治疗酒精依赖:一项安慰剂对照试验。
Alcohol Clin Exp Res. 1996 Apr;20(2):307-12. doi: 10.1111/j.1530-0277.1996.tb01644.x.
4
Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.阿贝卡尼治疗广泛性焦虑症:阿贝卡尼与丁螺环酮两个剂量范围的安慰剂对照比较
J Clin Psychiatry. 1997;58 Suppl 11:19-23.
5
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.文拉法辛缓释剂与丁螺环酮治疗广泛性焦虑障碍门诊患者的疗效、安全性及耐受性
J Clin Psychiatry. 1999 Aug;60(8):528-35. doi: 10.4088/jcp.v60n0805.
6
Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.评估丁螺环酮对广泛性焦虑症患者的疗效,这些患者从先前使用劳拉西泮的治疗转换为使用丁螺环酮:一项安慰剂对照、双盲研究。
J Clin Psychopharmacol. 1995 Feb;15(1):12-9. doi: 10.1097/00004714-199502000-00003.
7
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.阿普唑仑与丁螺环酮治疗广泛性焦虑症门诊患者的疗效比较
Psychopharmacology (Berl). 1991;105(3):428-32. doi: 10.1007/BF02244440.
8
Buspirone in the long-term treatment of generalized anxiety disorder.
J Clin Psychiatry. 1987 Dec;48 Suppl:3-6.
9
Anxiety and alcoholism: a serotonin link.
Br J Psychiatry Suppl. 1991 Sep(12):34-9.
10
Buspirone in depressed outpatients: a controlled study.
Psychopharmacol Bull. 1990;26(2):163-7.

引用本文的文献

1
Pharmacotherapies and personalized medicine for alcohol use disorder: a review.药物治疗和个体化医学在酒精使用障碍中的应用:综述。
Pharmacogenomics. 2020 Oct;21(15):1117-1138. doi: 10.2217/pgs-2020-0079. Epub 2020 Aug 18.
2
Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms-A bayesian network meta-analysis.伴有酒精使用障碍和抑郁症状患者的药物治疗效果:一项贝叶斯网络荟萃分析。
CNS Neurosci Ther. 2020 Nov;26(11):1185-1197. doi: 10.1111/cns.13437. Epub 2020 Jul 19.
3
Treatment for Substance Use Disorder With Co-Occurring Mental Illness.
共病精神疾病的物质使用障碍治疗
Focus (Am Psychiatr Publ). 2019 Apr;17(2):88-97. doi: 10.1176/appi.focus.20180042. Epub 2019 Apr 10.
4
Serotonergic Neuroplasticity in Alcohol Addiction.酒精成瘾中的5-羟色胺能神经可塑性
Brain Plast. 2016 Jun 29;1(2):177-206. doi: 10.3233/BPL-150022.
5
Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.共病酒精依赖与焦虑症的治疗:科学证据综述与治疗建议
Front Psychiatry. 2017 Sep 22;8:173. doi: 10.3389/fpsyt.2017.00173. eCollection 2017.
6
Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.酒精中毒复发预防:最新进展和未来可能。
CNS Drugs. 1997 Apr;7(4):313-27. doi: 10.2165/00023210-199707040-00004.
7
The Relationship Between Generalized Anxiety Symptoms and Treatment Dropout Among Women in Residential Treatment for Substance Use Disorders.物质使用障碍住院治疗女性中广泛性焦虑症状与治疗中断之间的关系
Subst Use Misuse. 2016 Jun 6;51(7):835-9. doi: 10.3109/10826084.2016.1155612. Epub 2016 Apr 20.
8
Perils of Pragmatic Psychiatry: How We Can Do Better.实用主义精神病学的风险:我们如何能做得更好。
HSOA J Psychiatry Depress Anxiety. 2016;2(1). doi: 10.24966/pda-0150/100002. Epub 2016 Feb 23.
9
Treatment of co-occurring anxiety disorders and substance use disorders.共病焦虑症和物质使用障碍的治疗。
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):99-111. doi: 10.1097/HRP.0000000000000058.
10
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.